I keep hearing that cannabis was moved from Schedule I to Schedule III. What does this actually mean in practice? Is it now federally legal? Can doctors prescribe it? What changed for regular users?
Policy & Advocacy Editor
The rescheduling of cannabis from Schedule I to Schedule III in 2024 was a historic milestone — but it is important to understand what it did and did not change.
The Controlled Substances Act (CSA) classifies drugs into five schedules based on medical use and abuse potential. Schedule I (heroin, LSD, previously cannabis) means "no accepted medical use and high abuse potential." Schedule III (anabolic steroids, ketamine, buprenorphine) means "accepted medical use with moderate to low physical dependence potential."
1. Research barriers reduced. Schedule I drugs face the most restrictive research requirements. Schedule III drugs can be studied with standard DEA researcher registration, without the special Schedule I protocols that previously made cannabis research extremely difficult. This is the most significant practical change.
2. Veterans Affairs. VA physicians may now be able to discuss cannabis with patients in a way they could not under Schedule I. The VA is still developing its policies.
3. Tax treatment (280E). Under Schedule I, cannabis businesses could not deduct normal business expenses under IRS Code 280E. Schedule III businesses can deduct expenses. This is a massive financial change for the cannabis industry — effectively reducing the tax burden on legal cannabis businesses by 30–40%.
4. Stigma reduction. The federal acknowledgment that cannabis has accepted medical use is symbolically significant.
1. Cannabis is still federally illegal. Schedule III substances are still controlled substances. Possession, sale, and distribution without federal authorization remain federal crimes.
2. State laws still govern retail. The rescheduling did not create a federal framework for legal cannabis sales. State laws still determine whether you can buy cannabis at a dispensary.
3. Doctors cannot prescribe it. Schedule III substances can be prescribed, but only FDA-approved formulations. The only FDA-approved cannabis-derived drug is Epidiolex (CBD for epilepsy). Doctors cannot write prescriptions for dispensary cannabis.
4. Interstate commerce is still illegal. Transporting cannabis across state lines remains a federal crime.
5. Banking issues largely remain. While the tax situation improved, most banking restrictions remain because cannabis is still a controlled substance.
Rescheduling was a significant step but not legalization. The most impactful changes are for researchers and cannabis businesses. For regular consumers, the practical day-to-day impact is minimal — state law still governs your ability to purchase and use cannabis.
Verified Legal Professional
The 280E tax change is worth emphasizing more. Under Schedule I, cannabis businesses were paying effective tax rates of 60–80% because they could not deduct ordinary business expenses (rent, salaries, utilities). This was financially devastating for many legal operators and gave the illicit market a massive price advantage.
Under Schedule III, cannabis businesses can deduct normal business expenses, reducing their effective tax rate to something closer to 25–35%. This is expected to significantly improve the financial viability of legal cannabis businesses and help them compete with the illicit market on price.
For consumers, this may eventually translate to lower prices at dispensaries as the legal market becomes more financially sustainable.